SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as the memory sector rallies on AI-driven supply constraints and rumors of a potential geopolitical peace deal, fueling community speculation about a significant price run-up before earnings. While investors debate the sustainability of record data center infrastructure spending, sentiment remains highly bullish with active discussions regarding PT upgrades, historical cyclical shifts, and institutional accumulation.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is facing significant volatility and investor frustration as market participants debate its valuation relative to the upcoming SpaceX IPO, with many questioning the fund's lack of transparency regarding management actions and recent dilution. While some investors see the current pullback as a bargain opportunity to gain exposure to a basket of high-growth tech firms including Anthropic and OpenAI, others are concerned that the fund's premium is evaporating now that direct access to its largest holdings is becoming possible.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Investors are actively debating the sustainability of the semiconductor rally as SOXL experiences heightened volatility, with community sentiment split between those viewing recent pullbacks as prime accumulation opportunities and others concerned about significant leverage decay and potential market correction. The conversation is largely centered on gauging new support levels amid shifting geopolitical narratives and the highly anticipated upcoming IPO of SpaceX, which traders are closely watching for its broader impact on market liquidity.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently driving intense market activity following its massive IPO, with investors debating the sustainability of its multi-trillion dollar valuation amidst limited float and high-profile retail interest. Community discourse remains deeply divided between those viewing it as a historic growth opportunity and skeptics concerned about long-term profitability and the risks of a potential post-IPO volatility spike.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as investors react to the company's $180 million stock offering and the recent Phase 3 trial success for its hereditary angioedema therapy, Lonvo-z. While the community is actively debating the dilution impact of the offering against the stock's long-term commercial potential, many are pointing to institutional backing and a significant short interest as catalysts for potential future price volatility.

Direxion Shares ETF Trust - Direxion Daily MU Bull 2X ETF

Direxion Daily MU Bull 2X Shares

Direxion Daily MU Bull 2X Shares ($MUU) is surging as investors aggressively pile into Micron-linked leveraged plays to capture the ongoing memory super cycle and high-bandwidth memory (HBM) demand. The community is actively debating the merits of holding this leveraged ETF long-term versus day trading, with many participants citing analyst upgrades and long-term supply constraints as primary drivers for the bullish sentiment.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing significant volatility as community sentiment splits between retail investors accumulating shares on the dip and bears highlighting concerns over cash burn and competitive pressures. Sentiment remains heavily focused on the company's path to profitability and potential short squeeze scenarios, with traders closely monitoring technical support levels and recent institutional ownership data.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is experiencing high volatility as investors weigh strong underlying profitability against persistent selling pressure, leading to significant community debate over whether the stock is a deep-value turnaround play or a long-term value trap. The stock has become a primary focal point for traders debating the impact of recent institutional accumulation and aggressive insider sentiment, with many actively discussing its positioning against streaming competitors in the current market climate.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital is trending as investors weigh its pivot from a bitcoin-focused miner to an AI infrastructure and data center operator, an evolution bolstered by community discussions surrounding a potential long-term decoupling from bitcoin price volatility. While retail sentiment remains polarized between frustration over management's execution and optimism regarding the company's energy assets and institutional backing, trading activity is dominated by heavy options volume and speculative interest in the timing of hyperscaler tenant deals.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. The company operates through the OSS and OSS Europe segments. One Stop Systems was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is seeing significant momentum following strong quarterly earnings that highlighted record bookings and robust revenue growth. The community is actively discussing its position as a key player in edge AI infrastructure, with investors closely watching for potential defense contracts and potential index inclusion to drive further upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE)

Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE...

Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm PR Newswire NEW YORK, June 4, 2026 NEW YORK, June 4, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...

Ultragenyx (RARE) Down 13.6% Since Last Earnings Report: Can It Rebound?

Ultragenyx (RARE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year

Key PointsKrensavage bought 241,245 Ultragenyx Pharmaceutical shares last quarter...

RARE Q1 Loss Wider Than Expected, Sales Down Y/Y on Seasonal Effect

Ultragenyx posts a wider-than-expected Q1 loss as Crysvita sales fall on seasonal effects, while Evkeeza and Dojolvi revenue growth partially offset declines.

Wells Fargo & Company Issues Positive Forecast for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price

Wells Fargo & Company upped their price target on Ultragenyx Pharmaceutical from $45.00 to $47.00 and gave the company an "overweight" rating in a research report on Wednesday...

Wedbush Issues Pessimistic Forecast for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price

Wedbush dropped their price objective on Ultragenyx Pharmaceutical from $27.00 to $26.00 and set a 'neutral' rating for the company in a research report on Wednesday...

Universal Beteiligungs und Servicegesellschaft mbH Has $323,000 Position in Ultragenyx Pharmaceutical Inc. $RARE

Universal Beteiligungs und Servicegesellschaft mbH decreased its position in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) by 84.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 14,094 shares of the...

Ultragenyx Pharmaceutical Q1 Earnings Call Highlights

Ultragenyx Pharmaceutical (NASDAQ:RARE) executives said the company is positioned for what Chief Executive Officer Emil Kakkis described as a "transformative" year, pointing to expectations for growing revenue, potential approvals for two gene therapies, and a key late-stage readout for its Angelman...

Ultragenyx Pharmaceutical (NASDAQ:RARE) Releases Earnings Results, Beats Expectations By $1,000.50 EPS

Ultragenyx Pharmaceutical (NASDAQ:RARE - Get Free Report) announced its quarterly earnings data on Tuesday. The biopharmaceutical company reported $999.00 EPS for the quarter, beating analysts' consensus estimates of ($1.50) by $1,000.50. Ultragenyx Pharmaceutical had a negative return on equity of...

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

RAREUltragenyx Pharmaceutical Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RARE News